Researchers have uncovered a surprising way the brain switches pain on, revealing that neurons can release an enzyme outside ...

Tulane researchers discovered a new pain signaling mechanism that could lead to safer, more effective treatments and reshape ...

Researchers at Tulane University, with a team of colleagues from eight other universities, have discovered a new nerve cell signaling mechanism that could transform our understanding of pain and lead ...

Neuropathic pain, a chronic condition resulting from nervous system lesions or diseases, remains a formidable clinical challenge due to its complex and ...

Pain is a constant, complex companion that clinicians often struggle to understand and measure for people living with sickle ...

Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic ...

Scientists have discovered a brain circuit that gives pain its emotional sting, explaining why some hurts linger as suffering. The breakthrough challenges our beliefs about how we process pain and may ...

(RTTNews) - Artelo Biosciences, Inc. (ARTL), Monday, announced favorable results from its Phase 1 Single Ascending Dose or SAD clinical trial evaluating ART26.12, a first-in-class, orally administered ...

SOLANA BEACH, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop ...

Background/aims To identify the risk factors for neuropathic corneal pain (NCP) following corneal refractive surgery and to report its clinical manifestations, imaging and proteomic characteristics.